Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

406
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
406
Skin Cancer01:30

Skin Cancer

6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

373
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
373

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging Appearance of Heavy Eye Syndrome.

Radiology·2025
Same author

Tumefactive Perivascular Spaces Causing Obstructive Hydrocephalus.

Radiology·2022
Same author

The patent track sign.

Abdominal radiology (New York)·2017
Same journal

Multimodal artificial intelligence models for liver fibrosis staging: a scoping review.

Abdominal radiology (New York)·2026
Same journal

Transurethral ultrasound ablation for prostate cancer: MRI-based pre-treatment planning and post-treatment assessment-what the radiologist needs to know.

Abdominal radiology (New York)·2026
Same journal

Segmental colitis associated with diverticulosis (SCAD): imaging features, diagnostic pitfalls, and multidisciplinary correlation.

Abdominal radiology (New York)·2026
Same journal

Interreader agreement for image quality, observation detection, and proposed AMRI-LI-RADS classification in non-contrast abbreviated MRI for hepatocellular carcinoma surveillance among early-to-mid career radiologists.

Abdominal radiology (New York)·2026
Same journal

Preoperative CT-based radiomics of suprapancreatic adipose tissue for predicting high-difficulty lymph node dissection in gastric cancer.

Abdominal radiology (New York)·2026
Same journal

4D flow MRI for the evaluation of venous anatomy and flow in renal cell carcinoma with venous tumor thrombus: a pictorial essay.

Abdominal radiology (New York)·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration
05:30

Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration

Published on: May 19, 2023

1.9K

The T2-dark spot sign

Saravana Kumar Swaminathan1,2

  • 1Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore, Singapore. saravanakumar.swaminathan@mohh.com.sg.

Abdominal Radiology (New York)
|February 1, 2017
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
05:12

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome

Published on: September 19, 2019

7.0K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.3K

Related Experiment Videos

Last Updated: Mar 8, 2026

Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration
05:30

Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration

Published on: May 19, 2023

1.9K
Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
05:12

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome

Published on: September 19, 2019

7.0K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.3K